Drug Profile
HLX 801
Alternative Names: HLX-801; NSC 732011; SR-16157Latest Information Update: 01 Mar 2022
Price :
$50
*
At a glance
- Originator SRI International
- Class Amines; Antineoplastics; Cyclopentanes; Phenanthrenes; Small molecules
- Mechanism of Action Estrogen receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- No development reported Breast cancer